21014 Federal Register / Vol. 89, No. 59 / Tuesday, March 26, 2024 / Notices 

automated collection techniques or 

other forms of information technology. 

This information collection is subject 

to the PRA. A Federal agency generally 

cannot conduct or sponsor a collection 

of information, and the public is 

generally not required to respond to an 

information collection, unless the OMB 

approves it and displays a currently 

valid OMB Control Number. In addition, 

notwithstanding any other provisions of 

law, no person shall generally be subject 

to penalty for failing to comply with a 

collection of information that does not 

display a valid OMB Control Number. 

See 5 CFR 1320.5(a) and 1320.6. 

DOL seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOL notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Agency: DOL–OWCP. 

Title of Collection: Rehabilitation 

Action Report. 

OMB Control Number: 1240–0008. 

Affected Public: Private Sector— 

Businesses or other for-profits; Not-forprofit institutions. 

Total Estimated Number of 

Respondents: 6,136. 

Total Estimated Number of 

Responses: 6,136. 

Total Estimated Annual Time Burden: 

1,043 hours. 

Total Estimated Annual Other Costs 

Burden: $0. 

(Authority: 44 U.S.C. 3507(a)(1)(D)) 

Michelle Neary, 

Senior Paperwork Reduction Act Analyst. 

[FR Doc. 2024–06358 Filed 3–25–24; 8:45 am] 

BILLING CODE 4510–CH–P 

DEPARTMENT OF LABOR 

Agency Information Collection 

Activities; Comment Request; 

Authorization and Certification/Letter 

of Medical Necessity, CA–26/CA–27; 

Correction 

ACTION: Request for public comments; 

correction. 

SUMMARY: The Department of Labor 

(DOL), Office of Workers’ Compensation 

Programs, is correcting a notice that 

appeared in the Federal Register on 

January 26, 2024. After publication of 

the notice, the DOL discovered that the 

information provided in the 

SUPPLEMENTARY INFORMATION section 

contained several errors. DOL is issuing 

this correction to provide the correct 

information. 

FOR FURTHER INFORMATION CONTACT: 

Anjanette Suggs, Office of Workers’ 

Compensation Programs, OWCP, at 

suggs.anjanette@dol.gov (email); (202) 

354–9660 (phone). 

SUPPLEMENTARY INFORMATION: 

Correction 

In FR. Doc. 2024–01535 appearing at 

89 FR 5263 in the Federal Register of 

Friday, January 26, 2024, on page 5264, 

in the third column, the following 

corrections are made to the 

SUPPLEMENTARY INFORMATION section, I. 

Background subsection: 

1. The first four full paragraphs of that 

third column are corrected to read as 

follows: 

OWCP believes that the the two forms 

used to monitor compound and opiate 

medication further strengthens medical 

management procedures for prescription 

drugs, assist our stakeholders in 

controlling costs afrom medically 

unnecessary treatements, and lessens 

the impact of potential drug addiction 

and medical fraud. However, OWCP is 

bifurcating the CA–26 from this 

collection so that it may be transferred 

to 1240–0NEW where it will be renamed 

OWCP–26. (The OWCP–26 will be 

updated to be applicable in all of 

OWCP’s program areas; otherwise, it 

will remain the same. The public and 

stakeholders for all programs will have 

opportunity to comment on the new 

form with the upcoming publication of 

the 60-day Federal Register Notice for 

1240–0NEW.) 

A major goal of the FECA program is 

to return an injured employee back to 

employment as soon as medically 

feasible. The CA–27 form is a means for 

injured workers to continue receiving 

opiod drugs only where medically 

necessary and simultaneously gives 

OWCP greater oversight in monitoring 

opioid use. 

OWCP has issued regulations relating 

to its authority to require prior 

authorization for medical treatment 

which will now be applied through the 

CA–27 to opioids. (20 CFR 10.310, 

10.800 & 10.809). Requiring Prior 

Authorization will assist OWCP in 

determining whether the prescribed 

medication will assist in curing, giving 

relief, and lessening the degree of 

disability. FECA further provides OWCP 

the authority to conduct such 

investigation as necessary before making 

an award of compensation (including 

the need for medical treatment by 

certain prescription drugs). 5 U.S.C. 

8124(a)(2). Finally, 5 U.S.C. 8149 

provides OWCP the authority to 

prescribe rules and regulations 

necessary for the administration of 

FECA. 

As such, the CA–27, Authorization 

Request form and Certification/Letter of 

Medical Necessity or Opioid 

Medications, fulfill these requirements 

and obligations under the FECA. 

2. On page 5265, in the first column, 

the following corrections are made to 

the summary of the collection contained 

in subsection III. Current Actions: 

Type of Review: Revision. 

Agency: Office of Workers’ 

Compensation Programs, Division of 

Federal Employees’ Longshore, and 

Harbor Workers’ Compensation, OWCP/ 

DFELHWC. 

OMB Number: 1240–0055. 

Affected Public: Individuals or 

households; business or other for-profit. 

Number of Respondents: 78. 

Frequency: On occasion. 

Number of Responses: 490. 

Annual Burden Hours: 245 hours. 

Annual Respondent or Recordkeeper 

Cost: $28,116.20. 

Anjanette Suggs, 

Certifying Officer. 

[FR Doc. 2024–06361 Filed 3–25–24; 8:45 am] 

BILLING CODE 4510–CH–P 

DEPARTMENT OF LABOR 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request; OSHA 

Outreach Training Program and OSHA 

Training Institute Education Centers 

Program Forms 

ACTION: Notice of availability; request 

for comments. 

SUMMARY: The Department of Labor 

(DOL) is submitting this Occupational 

Safety & Health Administration (OSHA)- 

sponsored information collection 

request (ICR) to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995 

(PRA). Public comments on the ICR are 

invited. 

DATES: The OMB will consider all 

written comments that the agency 

receives on or before April 25, 2024. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Nicole Bouchet by telephone at 202– 

693–0213, or by email at DOL_PRA_

PUBLIC@dol.gov. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 59 / Tuesday, March 26, 2024 / Notices 21015 

SUPPLEMENTARY INFORMATION: OSHA’s 

Office of Training and Educational 

Programs is designed to recognize and 

promote excellence in safety and health 

training. The OSHA Training Institute’s 

(OTI) Education Centers offer courses 

for the private sector and other federal 

agency personnel at locations 

throughout the United States. OSHA 

extends its training reach to workers 

through its various Outreach Training 

Programs. Through the Outreach 

Training Programs, qualified 

individuals complete an OSHA trainer 

course and become authorized to teach 

student courses. The collection of 

information requirements contained in 

these programs are necessary to evaluate 

the applicant organization and to 

implement, oversee, and monitor the 

OTI Education Centers and Outreach 

Training Programs, courses and trainers. 

For additional substantive information 

about this ICR, see the related notice 

published in the Federal Register on 

December 28, 2023 (88 FR 89730). 

Comments are invited on: (1) whether 

the collection of information is 

necessary for the proper performance of 

the functions of the Department, 

including whether the information will 

have practical utility; (2) the accuracy of 

the agency’s estimates of the burden and 

cost of the collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

ways to enhance the quality, utility and 

clarity of the information collection; and 

(4) ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

automated collection techniques or 

other forms of information technology. 

This information collection is subject 

to the PRA. A Federal agency generally 

cannot conduct or sponsor a collection 

of information, and the public is 

generally not required to respond to an 

information collection, unless the OMB 

approves it and displays a currently 

valid OMB Control Number. In addition, 

notwithstanding any other provisions of 

law, no person shall generally be subject 

to penalty for failing to comply with a 

collection of information that does not 

display a valid OMB Control Number. 

See 5 CFR 1320.5(a) and 1320.6. 

DOL seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOL notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Agency: DOL–OSHA. 

Title of Collection: OSHA Outreach 

Training Program and OSHA Training 

Institute Education Centers Program 

Forms. 

OMB Control Number: 1218–0262. 

Affected Public: Individuals or 

Households; Private Sector—Businesses 

or other for-profits, Not-for-profit 

institutions. 

Total Estimated Number of 

Respondents: 53,502 and 26. 

Total Estimated Number of 

Responses: 58,242. 

Total Estimated Annual Time Burden: 

16,377 hours. 

Total Estimated Annual Other Costs 

Burden: $0. 

(Authority: 44 U.S.C. 3507(a)(1)(D)) 

Nicole Bouchet, 

Certifying Official. 

[FR Doc. 2024–06360 Filed 3–25–24; 8:45 am] 

BILLING CODE 4510–26–P 

DEPARTMENT OF LABOR 

Office of the Worker’s Compensation 

Programs 

[OMB Control No. 1240–0NEW] 

Proposed of Information Collection; 

Authorization Request Form and 

Certification/Letter of Medical 

Necessity for Compounded Drugs 

(OWCP–26) 

AGENCY: Office of Workers’ 

Compensation (OWCP), Labor. 

ACTION: Request for public comments. 

SUMMARY: The Department of Labor, as 

part of its continuing effort to reduce 

paperwork and respondent burden, 

conducts a pre-clearance request for 

comment to provide the general public 

and Federal agencies with an 

opportunity to comment on proposed 

collections of information in accordance 

with the Paperwork Reduction Act of 

1995. This request helps to ensure that: 

requested data can be provided in the 

desired format; reporting burden (time 

and financial resources) is minimized; 

collection instruments are clearly 

understood; and the impact of collection 

requirements on respondents can be 

properly assessed. Currently, OWCP is 

soliciting comments on the information 

collection for Authorization Request 

Form and Certification/Letter of Medical 

Necessity for Compounded Drugs 

(OWCP–26). 

DATES: All comments must be received 

on or before May 28, 2024. 

ADDRESSES: You may submit comment 

as follows. Please note that late, 

untimely filed comments will not be 

considered. 

Written/Paper Submissions: Submit 

written/paper submissions in the 

following way: 

• Mail/Hand Delivery: Mail or visit 

DOL–OWCP/, Office of Workers’ 

Compensation Programs, U.S. 

Department of Labor, 200 Constitution 

Ave. NW, Room S–3524, Washington, 

DC 20210. 

• OWCP will post your comment as 

well as any attachments, except for 

information submitted and marked as 

confidential, in the docket at https://

www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Anjanette Suggs, Office of Workers’ 

Compensation Programs, OWCP, at 

suggs.anjanette@dol.gov (email); (202) 

354–9660 (phone). 

SUPPLEMENTARY INFORMATION: 

I. Background 

In 2013, the President of the United 

States, Barack Obama, signed a law, 

which provides greater federal oversight 

over compounding pharmacies that 

custom mix medication in bulk for 

patients who may benefit from 

prescriptions that are specific to their 

individual medical needs. See 

Compounding Quality Act, Public Law 

113–54, 127 Stat. 587 (2013). 

Compounded drugs have two or more 

ingredients and are offered as an 

alternative to Food and Drug 

Administration (FDA)-approved 

medications that do not meet an 

individual patient’s health needs, such 

as when a patient has an allergy that 

requires a medication to be made 

without a certain dye. See 

Compounding and the FDA: Questions 

and Answers, http://www.fda.gov/ 

Drugs/GuidanceComplianceRegulatory

Information/PharmacyCompounding/

ucm339764.htm. 

Compounded drugs are not FDAapproved. This means that the FDA 

does not verify the safety or 

effectiveness of compounded drugs. 

Consumers and health professionals rely 

on the drug approval process to ensure 

that drugs are safe and effective, and 

made in accordance with Federal 

quality standards. Compounded drugs 

also lack an FDA finding of 

manufacturing quality before they are 

marketed. 

Health risks associated with 

compounded drugs include the use of 

ingredients that may be sub- or superpotent, contaminated, or otherwise 

adulterated. Additionally, patients may 

use ineffective compounded drugs 

instead of FDA-approved drugs, which 

have been shown to be safe and 

effective. 


ddrumheller on DSK120RN23PROD with NOTICES1